Late preconditioning (PC) provides sustained and powerful protection against both reversible and irreversible ischemia/reperfusion injury. The underlying mechanisms of late PC have been extensively investigated in the hope of identifying new approaches to protect the ischemic myocardium. Thus far, however, most studies have been undertaken in animal models in which ischemia was imposed in the absence of other disease processes. Since pathologic conditions may interfere with the biochemical pathways that underlie late PC, the PC response is likely to be modified by systemic diseases. Therefore, there is an urgent need to examine the PC response in the presence of concurrent, clinically relevant abnormalities such as hypercholesterolemia (HC). It has been well documented that HC impairs nitric oxide (NO) formation and that NO plays a critical role in late PC, acting initially as a trigger and subsequently as a mediator of this phenomenon. The overall objective of this proposal is to investigate the late PC response in the presence of HC. Our fundamental hypothesis is that the cardioprotective effects of late PC are abrogated by HC, and that this is caused by NO insufficiency both at the level of trigger (immediately after the PC stimulus) and at the level of mediator (24 h later). We will first verify that both the anti-stunning and the anti-infarct effects of late PC are abolished in chronically-instrumented rabbits with HC; the dose dependent effects of HC will be established. We will then examine the effect of HC on the generation of NO that triggers the signal transduction events that initiate the late PC response. Furthermore, we will determine whether HC blocks formation of NO from the inducible NOS, which mediates the cardioprotection of late PC. The role of ADMA disregulation and DDAH activity in impairing eNOS-dependent NO generation during HC will be investigated. The role of tetrahydrobiopterin (BH4) deficiency in impairing the function of NO as a mediator of late PC will also be established. The ability of supplemental L-arginine, NO donors, and exogenous BH4 to reinstate the late PC response in the presence of HC will be investigated. This study will thoroughly test the concept that HC abrogates late PC by impairing the role of NO, and will interrogate the underlying mechanisms. The results may pave the way for therapeutic strategies aimed at restoring the late PC response in the clinically prevalent condition of HC. ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL074351-04
Application #
7093507
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Schwartz, Lisa
Project Start
2003-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2008-06-30
Support Year
4
Fiscal Year
2006
Total Cost
$251,205
Indirect Cost
Name
University of Louisville
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Wysoczynski, Marcin; Guo, Yiru; Moore 4th, Joseph B et al. (2017) Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence. J Am Coll Cardiol 69:1824-1838
Tang, Xian-Liang; Li, Qianhong; Rokosh, Gregg et al. (2016) Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at L Circ Res 118:1091-105
Tokita, Yukichi; Tang, Xian-Liang; Li, Qianhong et al. (2016) Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy. Circ Res 119:635-51
Tang, Xian-Liang; Rokosh, Gregg; Sanganalmath, Santosh K et al. (2015) Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction. Circ Heart Fail 8:757-65
Dimova, Neviana; Wysoczynski, Marcin; Rokosh, Gregg (2014) Stromal cell derived factor-1? promotes C-Kit+ cardiac stem/progenitor cell quiescence through casein kinase 1? and GSK3?. Stem Cells 32:487-99
Wysoczynski, Marcin; Solanki, Mitesh; Borkowska, Sylwia et al. (2014) Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction. Stem Cells 32:2502-15
Bolli, Roberto; Tang, Xian-Liang; Sanganalmath, Santosh K et al. (2013) Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128:122-31
Sanganalmath, Santosh K; Bolli, Roberto (2013) Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res 113:810-34
Obal, Detlef; Dai, Shujing; Keith, Rachel et al. (2012) Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion. Basic Res Cardiol 107:305
Madonna, Rosalinda; Rokosh, Gregg (2012) Insights into gene therapy for critical limb ischemia: the devil is in the details. Vascul Pharmacol 57:10-4

Showing the most recent 10 out of 21 publications